(Q46499838)

22 December 2017

title

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production (English)

1 reference

22 December 2017

1 reference

1 reference

Laine L

1 reference

22 December 2017

Sloane R

series ordinal

1 reference

22 December 2017

Ferretti M

series ordinal

1 reference

22 December 2017

Cominelli F

series ordinal

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

22 December 2017

Gastrointestinal Endoscopy

published in

1 reference

22 December 2017

volume

1 reference

22 December 2017

issue

1 reference

22 December 2017

page(s)

428-433

1 reference

22 December 2017

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

A double-blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Nonsteroidal antiinflammatory drugs--differences and similarities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2895%2970045-5

10.1016/S0016-5107(95)70045-5

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017